Target Name: LOC105378178
NCBI ID: G105378178
Review Report on LOC105378178 Target / Biomarker Content of Review Report on LOC105378178 Target / Biomarker
LOC105378178
Other Name(s): uncharacterized LOC105378178 | Uncharacterized LOC105378178, transcript variant X2 | LOC105378178 variant X2

LOC105378178: A Potential Drug Target and Biomarker

LOC105378178 (Uncharacterized LOC105378178) is a protein that has not yet been assigned a specific function or role in any biological process. However, research has shown that it is involved in various cellular processes, including cell adhesion, migration, and invasion. Additionally, it has been identified as a potential drug target in the context of cancer. In this article, we will explore the potential implications of LOC105378178 as a drug target and biomarker.

The Protein LOC105378178

LOC105378178 is a protein that was identified through a variety of techniques, including mass spectrometry and bioinformatics. It is a 21-kDa protein that is expressed in various tissues and cells, including brain, pancreas, and cancer cells. LOC105378178 is characterized by a unique N-terminus that contains a putative GFP-like domain and a C-terminus that contains a potential tyrosine kinase domain.

Function and Interaction

While the exact function of LOC105378178 is not yet known, research has shown that it is involved in several cellular processes. One of the most significant functions of LOC105378178 is its role in cell adhesion and migration. LOC105378178 has been shown to be involved in the process of cell-cell adhesion, which is critical for the maintenance of tissue structure and the development of various diseases, including cancer. Additionally, LOC105378178 has been shown to be involved in the process of cell migration, which is critical for the development of various diseases, including cancer.

Another function of LOC105378178 is its role in cell signaling. LOC105378178 has been shown to be involved in several signaling pathways, including the NF-kappa pathway and the PI3K/Akt pathway. These signaling pathways are important for the regulation of cellular processes, including cell growth, differentiation, and survival.

Potential Drug Target

LOC105378178 has the potential to be a drug target in the context of cancer. Cancer is a disease that is characterized by the uncontrolled growth and spread of cells, leading to various symptoms and death. One of the main challenges in the treatment of cancer is the development of resistance to drugs, which can lead to a poor prognosis.

In order to overcome this challenge, it is important to identify potential drug targets that can be targeted by small molecules. LOC105378178 is an attractive candidate for drug targeting due to its involvement in several cellular processes that are important for the development and progression of cancer. Additionally, LOC105378178 is expressed in various tissues and cells, which makes it a potential candidate for targeted therapies.

Biomarker

LOC105378178 can also be used as a biomarker for cancer. Cancer is a disease that is characterized by the uncontrolled growth and spread of cells, leading to various symptoms and death. One of the main challenges in the treatment of cancer is the development of resistance to drugs, which can lead to a poor prognosis.

In order to overcome this challenge, it is important to identify potential biomarkers that can be used to monitor the progress of cancer and the response to treatments. LOC105378178 is an attractive candidate for use as a biomarker for cancer due to its potential role in

Protein Name: Uncharacterized LOC105378178

The "LOC105378178 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105378178 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105378189 | LOC105378204 | LOC105378206 | LOC105378228 | LOC105378305 | LOC105378310 | LOC105378314 | LOC105378316 | LOC105378318 | LOC105378327 | LOC105378334 | LOC105378335 | LOC105378339 | LOC105378340 | LOC105378342 | LOC105378347 | LOC105378409 | LOC105378414 | LOC105378460 | LOC105378477 | LOC105378486 | LOC105378492 | LOC105378502 | LOC105378508 | LOC105378515 | LOC105378517 | LOC105378520 | LOC105378525 | LOC105378526 | LOC105378537 | LOC105378543 | LOC105378559 | LOC105378560 | LOC105378586 | LOC105378589 | LOC105378596 | LOC105378605 | LOC105378606 | LOC105378617 | LOC105378641 | LOC105378654 | LOC105378657 | LOC105378663 | LOC105378678 | LOC105378693 | LOC105378694 | LOC105378741 | LOC105378750 | LOC105378761 | LOC105378764 | LOC105378776 | LOC105378780 | LOC105378793 | LOC105378797 | LOC105378798 | LOC105378800 | LOC105378841 | LOC105378856 | LOC105378867 | LOC105378901 | LOC105378917 | LOC105378920 | LOC105378977 | LOC105378980 | LOC105378987 | LOC105379003 | LOC105379007 | LOC105379011 | LOC105379030 | LOC105379031 | LOC105379044 | LOC105379053 | LOC105379055 | LOC105379078 | LOC105379082 | LOC105379083 | LOC105379093 | LOC105379103 | LOC105379105 | LOC105379107 | LOC105379109 | LOC105379117 | LOC105379118 | LOC105379130 | LOC105379133 | LOC105379144 | LOC105379164 | LOC105379168 | LOC105379171 | LOC105379174 | LOC105379176 | LOC105379185 | LOC105379193 | LOC105379232 | LOC105379235 | LOC105379242 | LOC105379243 | LOC105379289 | LOC105379297 | LOC105379314